Insights into the pharmacological relevance of lysophospholipid receptors. - Wikidata - wikimedia - TriplyDB

Insights into the pharmacological relevance of lysophospholipid receptors.

Insights into the pharmacological relevance of lysophospholipid receptors.

http://www.wikidata.org/entity/Q35853199

about

Molecular mechanisms of large-conductance ca (2+) -activated potassium channel activation by ginseng gintonin Lysophospholipids and their receptors in the central nervous system Fingolimod: direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy Lipid phosphate phosphatases and their roles in mammalian physiology and pathology A novel highly potent autotaxin/ENPP2 inhibitor produces prolonged decreases in plasma lysophosphatidic acid formation in vivo and regulates urethral tension The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors Distinct phospholipase C-β isozymes mediate lysophosphatidic acid receptor 1 effects on intestinal epithelial homeostasis and wound closure.Lysophosphatidic acid receptor type 1 (LPA1) plays a functional role in osteoclast differentiation and bone resorption activity.Definition of a Novel Pathway Centered on Lysophosphatidic Acid To Recruit Monocytes during the Resolution Phase of Tissue Inflammation Identification of heparin-binding EGF-like growth factor (HB-EGF) as a biomarker for lysophosphatidic acid receptor type 1 (LPA1) activation in human breast and prostate cancers.Altered lysophosphatidic acid (LPA) receptor expression during hepatic regeneration in a mouse model of partial hepatectomy Sphingosine 1-phosphate receptor 3 and RhoA signaling mediate inflammatory gene expression in astrocytes.LPA receptor signaling: pharmacology, physiology, and pathophysiology.Lysophospholipid receptor nomenclature review: IUPHAR Review 8.Calcitonin controls bone formation by inhibiting the release of sphingosine 1-phosphate from osteoclasts.Role of LPA and the Hippo pathway on apoptosis in salivary gland epithelial cells Krüppel-like factor 5 incorporates into the β-catenin/TCF complex in response to LPA in colon cancer cells.Hydrophilic interaction chromatography based solid-phase extraction and MALDI TOF mass spectrometry for revealing the influence of Pseudomonas fluorescens on phospholipids in salmon fillet.A Global Map of Lipid-Binding Proteins and Their Ligandability in Cells.G Protein-Coupled Receptor and RhoA-Stimulated Transcriptional Responses: Links to Inflammation, Differentiation, and Cell Proliferation.The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate.Myocardin-Related Transcription Factor A and Yes-Associated Protein Exert Dual Control in G Protein-Coupled Receptor- and RhoA-Mediated Transcriptional Regulation and Cell Proliferation.Sphingosine 1-phosphate receptor 2 (S1P2) attenuates reactive oxygen species formation and inhibits cell death: implications for otoprotective therapy A mechanistically novel, first oral therapy for multiple sclerosis: the development of fingolimod (FTY720, Gilenya).Serum Autotaxin is a Marker of the Severity of Liver Injury and Overall Survival in Patients with Cholestatic Liver Diseases.Sphingosine 1-phosphate receptors are essential mediators of eyelid closure during embryonic development Lysophosphatidic acid induces vasodilation mediated by LPA1 receptors, phospholipase C, and endothelial nitric oxide synthase.Sphingosine 1-Phosphate Receptor Modulators and Drug Discovery.Matricellular protein Cyr61 bridges lysophosphatidic acid and integrin pathways leading to cell migration.Lysophosphatidic acid (LPA) and its receptor, LPA1 , influence embryonic schwann cell migration, myelination, and cell-to-axon segregation.Arguing the case for the autotaxin-lysophosphatidic acid-lipid phosphate phosphatase 3-signaling nexus in the development and complications of atherosclerosis.Lysophosphatidic Acid Pretreatment Attenuates Myocardial Ischemia/Reperfusion Injury in the Immature Hearts of Rats.Lysophospholipid receptor activation of RhoA and lipid signaling pathways.Lysophosphatidic acid (LPA) signalling in cell migration and cancer invasion: a focussed review and analysis of LPA receptor gene expression on the basis of more than 1700 cancer microarrays.Industrial natural product chemistry for drug discovery and development.Design of anticancer lysophosphatidic acid agonists and antagonists.Role of sphingomyelinases in neurological disorders.Single-cell profiling reveals GPCR heterogeneity and functional patterning during neuroinflammation.CD14 is a key mediator of both lysophosphatidic acid and lipopolysaccharide induction of foam cell formation.An in vivo screening system to identify tumorigenic genes.

P2860

Q21285088-EB648D12-8795-43BD-866B-CB951F7E5CD6 Q26859168-EEECECEA-00F2-4148-BD18-7991479DC222 Q27011473-7BF3CDD5-F422-4F39-A310-DF6B8463C405 Q28088430-0FD4F555-109C-4BD8-84C0-639D9FF54712 Q28538027-818CC1BA-EBDC-40EF-A82F-0305AD0A775F Q30486707-57A498B3-B87A-4F37-B91B-BC693F19EB48 Q30539636-DBE9D9EE-F071-4091-9B47-67BD1D34C058 Q30573574-50A9543E-12CB-458C-A85F-3E1333383246 Q30657993-97848518-3ED2-4386-9303-E9A10B726D67 Q33610285-6FF8CB21-37D9-4D24-8752-EB2C7913D4FD Q33720930-BDA77219-44FA-441A-A694-834CDD61336F Q33756197-779B7FD3-394B-46C3-9B18-3C0786A36F30 Q33825153-4A9028DF-79A0-4A56-8194-5D28F71DCA05 Q34025135-E061C864-32D2-4D97-9890-FB95D0CA98FF Q34383078-8E6A3FCA-0CA2-4E33-B9C6-5C6E0FAC8F2A Q34760307-C4A96A09-708E-4B80-A140-8007F9AD4189 Q35181424-D7D9406C-A411-4905-ADC6-7DF9B5C15DA6 Q35506079-BBC3B681-4DE0-427F-8D8D-BC27091D08BC Q35668656-3F5D92D9-27ED-4ACE-849E-5B166437E9FF Q35745964-8FC5C15F-586F-463A-B7A6-89C24B532591 Q36361669-53A26B89-8FD4-439A-819D-4A390C00613E Q36434018-CB800784-6FDF-4AC0-B3CB-605FC608684B Q36799651-EE2E5989-1C3E-44ED-BF68-EB5011A490D6 Q36960355-C86E5B49-11D2-421C-B99B-3D9371B0A149 Q37163154-8BD67950-945E-4CE2-9D2A-A38AAA8B0606 Q37226246-2796CB43-EFDC-4779-BD22-7657890A240A Q37503698-13C3BB9C-E485-46E3-AB12-92BCDB9F6152 Q37551932-3DC8F3FD-A556-4E4B-BC36-F94CC048E422 Q37608477-8AA6AD9C-D27D-4B9A-8493-35CB992D4B8B Q37615908-CCA3BB45-46BB-4C4B-AB5C-3077BE51448D Q37620329-60E59852-B741-4F0F-8CE1-1457EC5E85AA Q37712457-AEF320E0-B1D9-4FA3-A494-6657AF41BD27 Q38044174-2642F79E-A2FC-467A-A9DA-BFD04FE917DA Q38101074-425669EE-B90E-4114-A6D5-4BAC8DA066F3 Q38154186-FBF8FAFF-CFCE-4781-A639-78375B7E2878 Q38223013-219DE800-8559-4F9B-9512-7111B8B79DDE Q38560939-B8D2B485-7B8C-47D4-8110-477134ED77A0 Q38645945-B12EAD48-41F1-4FC5-A3CA-A0D914153559 Q38680111-C4C40C6E-CB41-4CEB-AA58-61E207CDA726 Q38742816-9CC6E75B-B441-4240-BA49-5732DFACDF49

P2860

Insights into the pharmacological relevance of lysophospholipid receptors.

http://www.wikidata.org/entity/Q35853199

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Insights into the pharmacological relevance of lysophospholipid receptors.

@ast

Insights into the pharmacological relevance of lysophospholipid receptors.

@en

type

label

Insights into the pharmacological relevance of lysophospholipid receptors.

@ast

Insights into the pharmacological relevance of lysophospholipid receptors.

@en

prefLabel

Insights into the pharmacological relevance of lysophospholipid receptors.

@ast

Insights into the pharmacological relevance of lysophospholipid receptors.

@en

P1433

Q35853199-36DF600E-34FA-493C-9C49-1C4B311111A9

P1476

Q35853199-75CDC117-072C-46B9-A23B-D3713EF8A9DA

P2093

Q35853199-0B5C3A51-7A61-489D-A61D-98D5B9050754

Q35853199-9973129A-AEBD-4B50-9BA7-184FDB0F129B

Q35853199-D2A50984-E784-4328-B073-4434C2E39FA5

P2860

Q35853199-0191B8B9-F53B-474C-9D7C-68D8E9C3249A

Q35853199-01A7923B-2F67-4EAC-9C11-40D1F3B28EF6

Q35853199-02A049A0-18FB-45A3-AE87-CDA8296A77AB

Q35853199-04CEEBAC-3703-4CF5-BA98-C8F46A7E4CF5

Q35853199-05610401-4CCF-4108-B5EC-D50324F7AA45

Q35853199-09AE9F14-A64F-415F-896B-0FD672FD5E80

Q35853199-0A384503-96C6-4893-ACB2-421317CEDCE0

Q35853199-0C1561E5-7EAC-4E64-9626-CAA1892058CF

Q35853199-0DCFB3EF-877E-4704-B435-2859D40CA512

Q35853199-138863B7-3741-4F62-AE94-C05464EF151D

P304

Q35853199-5FA1994B-1DB6-4466-8A11-1DEF4C0C812E

P31

Q35853199-53E58EF9-6B8C-4140-A454-C98F6A3C1BAF

P356

Q35853199-6D8FE8A2-5C51-411B-94B9-1D44B8B180F6

P407

Q35853199-0E83BDE1-6B73-4E02-871A-C55256093303

P433

Q35853199-C0B2B912-65E4-4FBA-8FA3-FA88CBCB55DA

P478

Q35853199-5CCED668-C8B8-43EE-962C-C844B5C21C10

P577

Q35853199-050D89B8-7BE1-4EA1-A5C7-956B025A87DC

P5875

Q35853199-DCE86E57-93DD-4E5E-AD8D-31F6EAD4E45C

P698

Q35853199-2FD17436-7717-478D-9494-3FD81C99AAC2

P921

Q35853199-7A60D568-3030-4ED1-A246-450DF8D99D3E

Q35853199-978A54AB-9F19-46D1-88FE-E2D10794B623

P932

Q35853199-5F5F57DF-CC6D-4F4C-BFD6-EE3A12E20DCA

P356

J.1476-5381.2011.01622.X

P1433

British Journal of Pharmacology

P1476

Insights into the pharmacological relevance of lysophospholipid receptors.

@en

P2093

Jerold Chun

http://www.w3.org/2001/XMLSchema#string

Richard Rivera

http://www.w3.org/2001/XMLSchema#string

Tetsuji Mutoh

http://www.w3.org/2001/XMLSchema#string

P2860

EDG6, a novel G-protein-coupled receptor related to receptors for bioactive lysophospholipids, is specifically expressed in lymphoid tissue

Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid

Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform

Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1

Identification of cDNAs encoding two G protein-coupled receptors for lysosphingolipids

G protein-coupled receptor P2Y5 and its ligand LPA are involved in maintenance of human hair growth

Cloning and characterization of a putative G-protein coupled receptor potentially involved in development

Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid

Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex

Characterization of plasma unsaturated lysophosphatidylcholines in human and rat

P304

829-844

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1476-5381.2011.01622.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

165

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51568682

http://www.w3.org/2001/XMLSchema#string

P698

21838759

http://www.w3.org/2001/XMLSchema#string

P921

fingolimod hydrochloride

P932

3312481

http://www.w3.org/2001/XMLSchema#string